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**Abstract**

We investigated the effects of genetic variants within PPP3CC, RORA, SP4, ST8SIA2 and ZNF804A genes in a Korean sample of 176 SCZ patients and 326 healthy controls and an Italian sample of 83 SCZ patients and 194 healthy controls. The PANSS was used to assess psychopathological severity and antipsychotic response (AR). Several clinical features were recorded in both samples. In the Korean sample RORA rs10438338 was associated with SCZ (p=0.03) as well as haplotype rs2282888-rs2237304-rs10272006-rs12673091 within SP4 gene (p=0.02). In the Italian sample 3 PPP3CC variants (rs11780915 p=0.006; rs10108011 p=0.01; rs2249098 p=0.0004), ZNF804A rs1344706 (p=0.02) and SP4 rs12673091 (p=0.02) were associated with SCZ. The haplotype rs11780915-rs10108011-rs2249098 within PPP3CC gene and the haplotype rs7603001-rs1344706 within ZNF804A gene were associated with SCZ as well (respectively p=0.03 and p=0.02). Further, several RORA variants were associated with AR (Korean sample: rs1871858 p=0.02; rs12900122 p=0.06, rs17204440 p=0.02, haplotype rs1020729-rs1871858 p=0.01; Italian sample: rs12900122 p=0.003). In the Italian sample also 2 SP4 variants (rs2282888 p=0.02; rs10272006 p=0.02) and ST8SIA2 rs4777989 (p=0.04) were associated with AR. Exploratory analyses suggested that: 1) PPP3CC, ST8SIA2 and SP4 genes may be implicated in the develop and severity of psychotic symptoms, 2) RORA gene may play a role in AR, particularly of negative symptomatology, as well as ZNF804A gene. Considering limitations linked to the sample size and candidate genes approach, our results further support a role for these gene in SCZ, as well as in AR. Analyses in well phenotyped samples could help researchers to refine the role of these genes for further, focused investigations.
